language
Language
Englishchevron_right
attach_money
Currency
$USDchevron_right
dark_mode
Dark Mode
policy
Privacy Policy
gavel
Terms of Service
RDNTRDNT

$69.81

-2.28
arrow_drop_down3.16%
Market closed·update27 Feb 2026 21:00

$69.0

-0.81
arrow_drop_down1.16%
Post-market·update28 Feb 2026 00:53
Day's Range
69.39-71.955
52-week Range
45.001-85.84

Chart

Loading chart...

Performance

Key Stats

Next Earnings Date2026-03-01
Next Earnings TimeAfter Market Close
Volume822.28K
Average Volume 30d833.64K

AI RDNT Summary

Powered by LiveAI
💰
-146.6
Valuation (P/E Ratio)
Negative P/E indicates losses. Consider Price-to-Sales.
📈
-0.43
EPS Growth (YoY)
EPS (TTM) is negative, indicating losses.
Show More 🔒

AI Scoreboard

Powered by LiveAI
🔒

Overall Analysis

Buy
68

RadNet demonstrates solid fundamental performance in the growing outpatient imaging sector, supported by technological advancements in AI. However, recent performance has been weak, and the stock shows bearish technical signals. Long-term investors may find value, but short-term caution is advised.

Strong

Thematic

75

RadNet is well-positioned within the expanding healthcare services and diagnostic imaging market, with a clear focus on digital health and AI integration.

Neutral

Fundamental

72

RadNet shows revenue growth, but profitability has been inconsistent, with recent negative EPS and fluctuating net margins. The company carries significant debt, although its cash position has improved.

Bearish

Technical

65

The stock is trading below its key moving averages, showing bearish momentum and signals across multiple timeframes. Immediate price action suggests downward pressure.

FactorScore
Healthcare Services Growth85
AI Integration in Radiology90
Digital Health Adoption80
Regulatory Landscape65
Competitive Landscape75
FactorScore
Valuation55
Profitability40
Growth70
Balance Sheet Health50
Cash Flow60
Earnings Per Share (EPS)30
FactorScore
Trend Analysis40
Momentum55
Volume Confirmation65
Support & Resistance75
Short-term Oscillators60

AI Investing Checklist

Powered by LiveAI
thumb_up

Bullish Points (7)

Company Profile & Services chevron_right

Diversified Imaging and Digital Health Services

RadNet, Inc. offers a broad range of outpatient diagnostic imaging services and has a growing digital health segment, including AI solutions for radiology, suggesting a diversified and forward-looking business model.

Revenue Growth chevron_right

Consistent Revenue Growth

Revenue has shown a consistent upward trend from $1.31 billion in 2021 to $1.83 billion in 2024, indicating increasing demand for its services.

Show More 🔒
thumb_down

Bearish Points (8)

Profitability chevron_right

Negative Net Income and Margins

The company has reported negative net income for TTM (-$29.4 million) and recent quarters (e.g., Q1 2025: -$37.9 million), with very thin or negative net margins, indicating profitability challenges.

Earnings Per Share (EPS) chevron_right

Inconsistent and Negative EPS

EPS estimates and reported figures have been volatile and often negative, with a reported EPS of -0.35 in Q2 2025 against an estimate of -0.13, indicating significant earnings misses and unprofitability.

Show More 🔒

Calendar

August 2025

8

Next Earnings Date

EPS Est.
Revenue Est.

H: $0.23

A: $0.16

L: $0.10

H: 492.62M

A: 488.06M

L: 483.10M

Profile

Websiteradnet.com
Employees (FY)11K
ISINUS7504911022
FIGI-

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Seasonals

2025
2024
2023
2022
2021

Price Target

71.57 USD

The 39 analysts offering 1 year price forecasts for RDNT have a max estimate of 80.00 and a min estimate of 60.00.

Debt Level and Coverage

Debt
Free cash flow
Cash & equivalents

Financial Position Analysis

Assets
Liabilities

Ownership

Free Float shares
67.2M (87.46%)
Closely held shares
9.64M (12.54%)
76.9M
Free Float shares
67.2M (87.46%)
Closely held shares
9.64M (12.54%)

Capital Structure

Market cap
4.31B
Debt
1.73B
Minority interest
0.00
Cash & equivalents
740.02M
Enterprise value
5.29B

Valuation - Summary

Market Cap
4.31B
Net income
-29.4M(-0.68%)
Revenue
1.41B(32.74%)
4.31B
Market Cap
4.31B
Net income
-29.4M(-0.68%)
Revenue
1.41B(32.74%)
Price to earning ratio (P/E)-146.60x
Price to sales ratio (P/S)3.10x

Valuation - Ratios

P/E
P/S

Revenue to Profit Conversion

Revenue
1.83B
COGS
1.58B
Gross Profit
249.12M
OpEx
137.84M
Operating Income
111.28M
Other & Taxes
108.48M
Net Income
2.79M

Balance Sheet

Total assets
Total liabilities
Liabilities to assets %

Income Statement

Revenue
Net Income
Net Margin

Cash Flow

Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Show More 🔒